FY2027 Earnings Forecast for UAMY Issued By HC Wainwright

United States Antimony Co. (NYSE:UAMY – Free Report) – Research analysts at HC Wainwright issued their FY2027 EPS estimates for shares of United States Antimony in a research note issued on Friday, November 13th. HC Wainwright analyst H. Ihle anticipates that the company will earn ($0.06) per share for the year. HC Wainwright currently has a “Buy” rating and a $6.50 target price on the stock. The consensus estimate for United States Antimony’s current full-year earnings is ($0.01) per share.

A number of other research analysts have also recently commented on the company. Wall Street Zen upgraded United States Antimony from a “strong sell” rating to a “sell” rating in a research note on Saturday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of United States Antimony in a research note on Monday, September 14th. Finally, Texas Capital raised United States Antimony to a “strong-buy” rating in a research note on Wednesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $8.75.

Read Our Latest Report on United States Antimony

United States Antimony Stock Performance

United States Antimony stock opened at $2.67 on Tuesday. The company has a market capitalization of $398.87 million, a PE ratio of -17.77 and a beta of 0.49. United States Antimony has a fifty-two week low of $2.53 and a fifty-two week high of $12.64. The firm has a 50 day moving average price of $3.72 and a 200 day moving average price of $6.86.

United States Antimony (NYSE:UAMY – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($0.06) earnings per share for the quarter. The company had revenue of $10.13 million for the quarter. United States Antimony had a negative return on equity of 7.73% and a negative net margin of 55.44%.

Institutional Investors Weigh In On United States Antimony

Several large investors have recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new position in United States Antimony in the 2nd quarter valued at approximately $82,365,000. Marshall Wace LLP increased its position in shares of United States Antimony by 228.0% during the third quarter. Marshall Wace LLP now owns 3,954,186 shares of the company’s stock worth $16,489,000 after acquiring an additional 2,748,800 shares during the period. Jump Financial LLC purchased a new stake in shares of United States Antimony during the third quarter worth $2,640,000. Bank of America Corp DE acquired a new stake in shares of United States Antimony in the second quarter valued at $4,208,000. Finally, Fifth Third Bancorp raised its stake in shares of United States Antimony by 23.8% in the third quarter. Fifth Third Bancorp now owns 494,996 shares of the company’s stock valued at $2,064,000 after acquiring an additional 95,216 shares in the last quarter. 9.49% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other United States Antimony news, Director Joseph Carrabba purchased 21,300 shares of United States Antimony stock in a transaction dated Tuesday, September 1st. The shares were acquired at an average price of $4.72 per share, with a total value of $100,536.00. Following the completion of the transaction, the director owned 198,401 shares of the company’s stock, valued at $936,452.72. This trade represents a 12.03% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Gary Evans purchased 20,000 shares of United States Antimony stock in a transaction dated Friday, August 28th. The shares were acquired at an average cost of $4.92 per share, for a total transaction of $98,400.00. Following the transaction, the chief executive officer directly owned 2,590,028 shares of the company’s stock, valued at approximately $12,742,937.76. This represents a 0.78% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 62,700 shares of company stock worth $298,592 over the last three months. Company insiders own 5.50% of the company’s stock.

About United States Antimony

(Get Free Report)

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.

Featured Stories

Earnings History and Estimates for United States Antimony (NYSE:UAMY)

Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.